Key statistics
On Friday, Actinium Pharmaceuticals Inc (ATNM:ASQ) closed at 1.45, 9.02% above its 52-week low of 1.33, set on Aug 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.47 |
---|---|
High | 1.49 |
Low | 1.41 |
Bid | 1.41 |
Offer | 1.58 |
Previous close | 1.47 |
Average volume | 311.61k |
---|---|
Shares outstanding | 31.20m |
Free float | 30.64m |
P/E (TTM) | -- |
Market cap | 45.86m USD |
EPS (TTM) | -1.40 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 23:30 GMT.
More ▼
- Actinium Pharmaceuticals Highlights Antibody Radiation Conjugate Program Developments and Reports Financial Results for the Third Quarter 2024
- Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
- Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical Oncology